NCT07561515

Brief Summary

This randomized clinical trial aims to evaluate the effectiveness of sound therapy in improving mental health and quality of life. Participants will be randomized into two groups: an intervention group using an acoustic resonance chamber and a control group using headphones. Both groups will be exposed to specific sound frequencies for nine minutes, once a week, for three weeks. The study investigates associations between sound therapy and levels of anxiety, stress, depression, and quality of life.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
110

participants targeted

Target at P50-P75 for not_applicable

Timeline
8mo left

Started Nov 2025

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress44%
Nov 2025Dec 2026

Study Start

First participant enrolled

November 2, 2025

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

March 14, 2026

Completed
2 months until next milestone

First Posted

Study publicly available on registry

May 1, 2026

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2026

Expected
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Last Updated

May 1, 2026

Status Verified

April 1, 2026

Enrollment Period

10 months

First QC Date

March 14, 2026

Last Update Submit

April 24, 2026

Conditions

Keywords

AnxietyStress, PsychologicalDepressionMental Health

Outcome Measures

Primary Outcomes (1)

  • Change from Baseline in Depression, Anxiety, and Stress Scores

    Assessed using the 21-item Depression, Anxiety, and Stress Scale (DASS-21). It assesses the severity of the core symptoms of depression, anxiety, and stress. It consists of three subscales. The total score for each subscale is calculated by summing the scores of the 7 relevant items (scored from 0 to 3) and multiplying by 2. Therefore, final scores for each subscale range from 0 to 42. Higher scores indicate greater symptom severity.

    Baseline, Day 7 post-intervention, Day 30 post-intervention, and Day 120 post-intervention.

Secondary Outcomes (6)

  • Change from Baseline in Quality of Life

    Baseline, Day 30 post-intervention, and Day 120 post-intervention.

  • Change from Baseline in Insomnia Severity

    aseline, Day 30 post-intervention, and Day 120 post-intervention.

  • Change from Baseline in Human Flourishing

    Baseline, Day 30 post-intervention, and Day 120 post-intervention.

  • Change from Baseline in Religiosity

    Baseline, Day 30 post-intervention, and Day 120 post-intervention.

  • Change from Baseline in General Health

    Baseline, Day 30 post-intervention, and Day 120 post-intervention.

  • +1 more secondary outcomes

Study Arms (2)

Acoustic Resonance Chamber

EXPERIMENTAL

Participants listen to specific sound frequencies inside a cylindrical acoustic resonance chamber (190 cm high and 90 cm in diameter), designed to optimize sound pressure distribution. Sessions last 9 minutes, once a week, for 3 weeks.

Procedure: Acoustic Resonance Sound Therapy

Control Group with Headphones

ACTIVE COMPARATOR

Participants listen to exactly the same sound frequencies, for the same duration (9 minutes, once a week, for 3 weeks), using headphones while remaining seated in a chair, outside the acoustic chamber environment.

Procedure: Control Group with Headphones

Interventions

Participants will receive sound therapy in 3 sessions, one session per week, each lasting 9 minutes. The protocol uses 9 sound frequencies as follows: session 1 will use the frequencies of 396 Hz (close to the note G), 639 Hz (close to the note E), and 963 Hz (close to the note B); session 2 will use the frequencies of 174 Hz (close to the note F), 417 Hz (close to the note G sharp), and 741 Hz (close to the note F sharp); and session 3 will use the frequencies of 285 Hz (close to the note D), 528 Hz (close to the note C), and 852 Hz (close to the note A), with each frequency applied for three minutes. Sound therapy is performed inside an acoustic resonance chamber, designed to optimize sound pressure distribution.

Acoustic Resonance Chamber

Participants will receive sound therapy in 3 sessions, one session per week, each lasting 9 minutes. The protocol uses 9 sound frequencies as follows: session 1 will use the frequencies of 396 Hz (close to the note G), 639 Hz (close to the note E), and 963 Hz (close to the note B); session 2 will use the frequencies of 174 Hz (close to the note F), 417 Hz (close to the note G sharp), and 741 Hz (close to the note F sharp); and session 3 will use the frequencies of 285 Hz (close to the note D), 528 Hz (close to the note C), and 852 Hz (close to the note A), with each frequency applied for three minutes. Participants receive the sound protocol through headphones, while remaining seated.

Control Group with Headphones

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age over 18 years
  • DASS-21 score consistent with at least mild anxiety, stress, or depression
  • Agreement to complete the 3-week protocol and follow-up questionnaires
  • Agreement not to practice other mind-body therapies during the study
  • Maintenance of conventional medical and/or psychological treatments

You may not qualify if:

  • Normal scores on the DASS-21
  • Presence of severe neurological, psychiatric, or clinical disorders
  • Use of high doses of medication that prevent standing for 9 minutes
  • Use of metal plates or devices in the body

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Federal University of Minas Gerais

Belo Horizonte, Minas Gerais, 30130-100, Brazil

Location

Related Publications (5)

  • Vignola RC, Tucci AM. Adaptation and validation of the depression, anxiety and stress scale (DASS) to Brazilian Portuguese. J Affect Disord. 2014 Feb;155:104-9. doi: 10.1016/j.jad.2013.10.031. Epub 2013 Oct 28.

    PMID: 24238871BACKGROUND
  • VanderWeele TJ. On the promotion of human flourishing. Proc Natl Acad Sci U S A. 2017 Aug 1;114(31):8148-8156. doi: 10.1073/pnas.1702996114. Epub 2017 Jul 13.

    PMID: 28705870BACKGROUND
  • Lucchetti G, Granero Lucchetti AL, Peres MF, Leao FC, Moreira-Almeida A, Koenig HG. Validation of the Duke Religion Index: DUREL (Portuguese version). J Relig Health. 2012 Jun;51(2):579-86. doi: 10.1007/s10943-010-9429-5.

    PMID: 21107911BACKGROUND
  • Fleck MP, Louzada S, Xavier M, Chachamovich E, Vieira G, Santos L, Pinzon V. [Application of the Portuguese version of the abbreviated instrument of quality life WHOQOL-bref]. Rev Saude Publica. 2000 Apr;34(2):178-83. doi: 10.1590/s0034-89102000000200012. Portuguese.

    PMID: 10881154BACKGROUND
  • Aravena PC, Almonacid C, Mancilla MI. Effect of music at 432 Hz and 440 Hz on dental anxiety and salivary cortisol levels in patients undergoing tooth extraction: a randomized clinical trial. J Appl Oral Sci. 2020;28:e20190601. doi: 10.1590/1678-7757-2019-0601. Epub 2020 May 11.

    PMID: 32401941BACKGROUND

MeSH Terms

Conditions

Psychological Well-BeingAnxiety DisordersDepressionStress, Psychological

Interventions

Control Groups

Condition Hierarchy (Ancestors)

Personal SatisfactionBehaviorMental DisordersBehavioral Symptoms

Intervention Hierarchy (Ancestors)

Epidemiologic Research DesignEpidemiologic MethodsInvestigative TechniquesResearch DesignMethods

Study Officials

  • Laylla CS Gendiroba, MSc

    Federal University of Minas Gerais

    STUDY CHAIR
  • UBIRATAN B Castro, MD, PhD

    Federal University of Minas Gerais

    STUDY CHAIR
  • Martinho M Sousa Filho, MD, MSc

    Federal University of Minas Gerais

    STUDY CHAIR
  • Rubens L C Tavares, MD, PhD

    Federal Universtiy of Minas Gerais

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD, PhD

Study Record Dates

First Submitted

March 14, 2026

First Posted

May 1, 2026

Study Start

November 2, 2025

Primary Completion (Estimated)

August 31, 2026

Study Completion (Estimated)

December 31, 2026

Last Updated

May 1, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will share
Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE

Locations